Daflon use in the hemorrhoids treatment

Abstract

The aim of this study was to assess the medical treatment  in the management  of primary grade-4 internal hemorrhoidal disease (IH) and external hemorrhoidal disease (CH).Detailed history and proctoscopic  examination to determine position,  size, and degree of hemorrhoids was conducted in all patients attending  our private clinic and Salah Aden General hospital  .The study was conducted over a one_ year  period. All were started on  Daflon, with dosage of  6 tablet per day for 4 days, 4 tablet per day for 3 days, and 2 tablet per day until the  signs and symptoms clinically disappear  or the  end of observation  time of 2months  were followed up weekly during the  study period and proctoscopic examination was conducted at each consultation.
Results: The mean age was 35 (range 20 60) years. The majority (58%) suffered primary grade IV internal hemorrhoidal disease and 42% with external hemorrhoidal disease. 56%patient had an excellent improvement,28% good,12%moderate and 4% nil.
Minor side effects of Daflon (mainly gastrointestinal symptoms) were encountered in 8% patients.